U.S. Markets open in 1 hr 18 mins

UCB SA (UCBJF)


Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
69.200.00 (0.00%)
At close: 12:11PM EDT
Full screen
Previous Close69.20
Open0.00
Bid0.00 x
Ask0.00 x
Day's Range0.00 - 0.00
52 Week Range
Volume0
Avg. Volume393
Market Cap12.46B
BetaN/A
PE Ratio (TTM)21.93
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Amgen (AMGN) Gets CRL for Osteoporosis Drug Evenity's BLA
    Zacks4 days ago

    Amgen (AMGN) Gets CRL for Osteoporosis Drug Evenity's BLA

    Amgen Inc. (AMGN) and partner UCB SA (UCBJF) announced that the FDA has issued a complete response letter (CRL) for the biologics license application (BLA) for Evenity (romosozumab).

  • Adamas Provides Positive Long-term Data on Parkinson's Drug
    Zackslast month

    Adamas Provides Positive Long-term Data on Parkinson's Drug

    Adamas Pharmaceuticals, Inc. (ADMS) presented expanded analysis from an ongoing open label phase III study EASE LID 2 on its lead candidate, ADS-5102 extended-release capsules.

  • UCB SA :UCBJF-US: Earnings Analysis: 2016 By the Numbers : February 28, 2017
    Capital Cube5 months ago

    UCB SA :UCBJF-US: Earnings Analysis: 2016 By the Numbers : February 28, 2017

    Categories: Yahoo Finance Get free summary analysis UCB SA reports financial results for the year ended December 31, 2016. We analyze the earnings along side the following peers of UCB SA – Shire PLC Sponsored ADR, Amgen Inc., Pfizer Inc., Biogen Inc. and Novartis AG Sponsored ADR (SHPG-US, AMGN-US, PFE-US, BIIB-US and NVS-US) that have also reported for ... Read more (Read more...)